Pharmaceutical / Biotechnology industry is more concerned over safety of the product, be it in terms of efficacy of the drug, packaging or delivering the product to the customers and other stakeholders. In all such scenarios, it is important to ensure that the product is safe for end usage. Testing place a key role in ensuring the safety of the product and ensures regulatory quality standards are maintained.
Global Biological Safety Testing Market was worth $1.76 billion in 2014 and is projected to reach $3.51 billion in 2020, at a compound annual growth rate of 12.23%.The growth in the end use industries (Pharmaceutical, Biotechnology) will drive the demand for safety testing of the products. Other factors like innovations in the Biotechnology industry, new drug developments and government regulations are also augmenting the need for safety testing.
North America leads the Global Biological Safety Testing market with a share of 37.5% in 2014, followed by Europe. On the other hand, Kits and reagents have a market share of more than 40% followed by instruments.
What the report offers
Market Definition for the Biological Safety Testing along with identification of key drivers and restraints for the market.
Market analysis Biological Safety Testing Market, with region specific assessments.
Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.
Identification and analysis of the Macro and Micro factors that affect the Biological Safety Testing Market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
Key points in table of content
- Research Methodology
- Executive Summary
- MARKET OVERVIEW
3.2 Industry Value Chain Analysis
3.3 Industry Attractiveness – Porter’s 5 Force Analysis
3.3.1 Bargaining Power of Suppliers
3.3.2 Bargaining Power of Consumers
3.3.3 Threat from new entrants
3.3.4 Threat from substitute products
3.3.5 Competitive rivalry within the industry
3.4 Industry Policies
- MARKET DYNAMICS
4.2.1 Growth in pharmaceutical and biotechnology industries
4.2.2 Innovation and new product launches
4.2.3 Increasing investments in biotechnology and life sciences research projects
4.3.1 Time consuming approval process
4.3.2 Strong entry barrier for new players
4.4.1 Biotechnology industry
- Biological Safety Testing Market Segmentation, Forecasts and Trends – by Volume, by Revenue
5.1 By Application
5.1.1 Blood related products
5.1.2 Cellular products
5.1.3 Tissue products
5.2 By Product
5.2.1 Kits and Reagents
5.3 By Tests
5.3.1 Sterility tests
5.3.2 Cell Line Authentication tests
5.3.3 Adventitious Agent Detection tests
5.3.4 Endotoxin tests
5.3.5 Other tests
5.4 By Region
5.4.1 North America
22.214.171.124 United States
126.96.36.199 United Kingdom
5.4.3 Asia Pacific
5.4.4 Latin America
5.4.5 Middle East and Africa
188.8.131.52 United Arab Emirates
184.108.40.206 Saudi Arabia
220.127.116.11 South Africa
- Global Vendor Market Share Analysis
- Competitive Intelligence – Company Profiles
7.2 Lonza group
7.3 Sigma Aldrich Corporation
7.5 Toxicon Corporation
7.8 WuXi PharmaTech
- Investment Analysis
8.1 Recent Mergers and Acquisitions
8.2 Investment Scenario and Opportunities
- Future of Biological Safety Testing market
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)